To investigate this phenomenon across a broader panel of cancers, we trained an RNAseq-based CTL score on this protein data with markers previously shown to be indicative of cytolytic CD8+ T-cells13 using elastic net regression on the breast cancer patient data. This evidence concerns the gene CD8A and breast cancer.